Advertisement
U.S. markets closed

Pulmonx Corporation (LUNG)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.61-0.18 (-2.65%)
At close: 04:00PM EST
6.61 0.00 (0.00%)
After hours: 04:02PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close6.79
Open6.80
Bid6.59 x 200
Ask6.66 x 200
Day's Range6.61 - 7.09
52 Week Range5.46 - 14.84
Volume213,615
Avg. Volume235,595
Market Cap261.015M
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-1.47
Earnings DateFeb 19, 2025 - Feb 24, 2025
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.50
  • Zacks

    Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?

    The consensus price target hints at an 117.7% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

  • GlobeNewswire

    Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

    REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced the company will be participating in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York on Wednesday, December 4, 2024, at 9:30 AM PT / 12:30 PM ET. A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://inv